Company Long-Term Loans and Borrowings: Amphastar (AMPH)

Public company logo of Amphastar (AMPH)

The current market quotes for Amphastar Pharmaceuticals (AMPH) visualized below on GURU.Markets rely on the human capital of Amphastar Pharmaceuticals (AMPH), where technologists develop rare dosage forms and the indicator stands at 0.62. The business generates profit through pricing power over critical drugs with low demand elasticity, while the company strictly adheres to medical regulations regarding waste processing and the energy efficiency of its production sites.

AMPH Amphastar Pharmaceuticals Company Long-Term Debts (07/04/2022 - 10/30/2026)

Summary analytical data breakdowns for Amphastar (AMPH)

- market price and analyst price targets:
Stock Price amphastar.com|AMPH - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Amphastar Pharmaceuticals|AMPH - Total Company Value
- book capitalization information:
Accounting Value per Share Amphastar Pharmaceuticals|AMPH - Book Capitalization|Market Capitalization to Book Value Ratio amphastar.com|AMPH - Cumulative Company Assets
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Amphastar Pharmaceuticals|AMPH - Long-Term Debt to Equity|Current Liabilities to Capital Amphastar Corp|AMPH - Company Total Debt|Debt to Book Capital Amphastar Pharmaceuticals|AMPH - Company Long-Term Debts|Company Short-Term Loans and Borrowings Amphastar Pharmaceuticals|Immediate Liquidity amphastar.com
- earnings and multiples data:
AMPH - Company Net Income
Fundamental company valuation:amphastar.com AMPH
Brand item of Amphastar Pharmaceuticals, Inc.

This indicator aggregates all credit obligations with a maturity of more than one year, capturing the dynamics of borrowed capital and its impact on financial stability. Analyzing the magnitude of long-term liabilities for Amphastar Pharmaceuticals (AMPH) allows for an assessment of the cost of scaling the production of inhalation drugs and generics, where a sharp upward trend may signal an increasing debt burden on operating profit.

Who Amphastar Pharmaceuticals competes with

Company Long-Term Debts haleon.com HLN|KVUE - Company Long-Term Debt|Company Long-Term Loans and Borrowings VRNA (Verona Pharma PLC)|Jyong Biotech Corp (MENS) - Company Long-Term Debt|Company Long-Term Liabilities Ligand Corp|AMRX (Amneal Pharmaceuticals) - Company Long-Term Debts|Company Long-Term Debts perrigo.com|Company Long-Term Liabilities ALVO (Alvotech SA)|LQDA (Liquidia Corp) - Company Long-Term Loans and Borrowings|Company Long-Term Debt Galapagos Genomics GLPG|ANI Pharmaceuticals Corp (ANIP) - Long-Term Debt|MNKD: Company Long-Term Liabilities|pacira.com - Amount of Long-Term Liabilities|SPRY: Company Long-Term Debts|Theravance Biopharma Inc - Company Long-Term Loans and Borrowings|AQST (Aquestive Pharma) - Company Long-Term Debts|Long-Term Debt scPharma SCPH|Company Long-Term Debt Tectonic Therapeutic, Inc. (TECX)|TNXP (tonixpharma.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debts SXTC (China SXT Pharmaceuticals, Inc.)|Company Long-Term Debts Eupraxia Pharmaceuticals, Inc. EPRX|BHST - Company Long-Term Debt|Invizyne (EXOZ) - Company Long-Term Liabilities|oramed.com (ORMP) - Company Long-Term Debt|Long-Term Liabilities ENTX (Entera Bio)|HYFT (MindWalk Holdings Inc.) - Company Long-Term Debts|ABVC: Company Long-Term Loans and Borrowings|Company Long-Term Debts CPIX|Company Long-Term Debts Quantum BioPharma Corp (QNTM)|Company Long-Term Debt FibroGen, Inc. FGEN|Long-Term Debt Volume telomirpharma.com (TELO)|RANI: Company Long-Term Liabilities|Synergy CHC Corp - Amount of Long-Term Liabilities|RLYB: Company Long-Term Debts|Lexaria Bioscience Corp. (LEXX) - Company Long-Term Debts|Company Long-Term Debt Pulmatrix, Inc.|PTHL: Company Long-Term Loans and Borrowings|Company Long-Term Liabilities APM (Aptorum Group Limited)|LYRA (Lyra Therapeutics Inc.) - Company Long-Term Loans and Borrowings|Company Long-Term Debt Impact BioMedical Inc IBO|TNFA (TNF Pharmaceuticals Inc.) - Long-Term Liabilities|cbdMD Corp - Company Long-Term Debts|Company Long-Term Loans and Borrowings PRFX (painreform.com)|CYTO: Company Long-Term Debts|Lipella Pharmaceuticals Inc (LIPO) - Company Long-Term Debts|Company Long-Term Debt Optinose|PIRS: Company Long-Term Loans and Borrowings|Company Long-Term Debt Procaps Group S.A. (PROC)|Company Long-Term Liabilities petrospharma.com PTPI|Company Long-Term Debts QLI (Qilian International Holding)|Company Long-Term Debts Acelyrin Inc. SLRN|TFF Pharma - Company Long-Term Debts